Skip to content
    Real-World Studies

    Longer Travel Time Linked to Less Radiotherapy and More Surgery in Non-Metastatic Prostate Cancer

    Dagnino et alCancer medicine

    Longer Travel Time Linked to Less Radiotherapy and More Surgery in Non-Metastatic Prostate Cancer
    In a cohort study of 132,939 men with non-metastatic prostate cancer diagnosed between 2000 and 2015 across metropolitan-area cancer registries in seven US states (follow-up through 2018), investigators examined how driving time to the hospital was associated with receipt of definitive treatment. Overall, 37.0% of men received no treatment, 41.0% underwent radical surgery, and 22.0% received radiotherapy. Travel time was estimated with Google Maps driving-time isochrones applied to geomasked residential addresses.
    In covariate-adjusted multinomial logistic regression, longer driving time (≥90 vs <30 minutes) was associated with higher odds of radical prostatectomy (aOR 1.08; 95% CI, 1.03–1.12) and lower odds of radiotherapy (aOR 0.72; 95% CI, 0.69–0.76). The association between longer driving time and surgery was stronger among men in the most deprived neighborhood socioeconomic quintile (nSES Q1 aOR 1.33; 95% CI, 1.21–1.45 vs Q5 aOR 0.94; 95% CI, 0.86–1.04), in low-density areas (aOR 1.16; 95% CI, 1.09–1.24 vs high density aOR 1.03; 95% CI, 0.98–1.09), and with regional disease (aOR 1.30; 95% CI, 1.14–1.48 vs localized aOR 1.05; 95% CI, 1.00–1.09). Longer driving time was mostly associated with lower odds of radiotherapy across sociodemographic subgroups.
    The authors concluded that higher travel time was associated with lower radiotherapy receipt but higher surgery use in deprived and rural patients, and that these associations warrant further investigation. As an observational registry analysis, the study does not establish why treatment choices differed.

    Key Takeaways

    • Driving time of ≥90 vs <30 minutes was associated with lower odds of radiotherapy (aOR 0.72; 95% CI, 0.69–0.76) and higher odds of radical prostatectomy (aOR 1.08; 95% CI, 1.03–1.12) among 132,939 men with non-metastatic prostate cancer.
    • The travel time–surgery association was stronger in the most deprived neighborhoods (nSES Q1 aOR 1.33), low-density areas (aOR 1.16), and regional disease (aOR 1.30); the authors call for further investigation rather than inferring a cause.